Frinsulin Biotech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Frinsulin Biotech General Information

Description

Operator of a medical firm intended to develop a diabetes drug to improve insulin resistance. The company is researching new drugs based on the mechanism of action for insulin resistance, enabling medical practitioners to help patients treat metabolic diseases caused by insulin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 207 Venture Building
  • 125 Gwahak-ro, Yuseong-gu
  • Daejeon
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 207 Venture Building
  • 125 Gwahak-ro, Yuseong-gu
  • Daejeon
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Frinsulin Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 09-Dec-2024 Completed Startup
2. Accelerator/Incubator 01-Jun-2023 Completed Startup
1. Early Stage VC Completed Startup
To view Frinsulin Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Frinsulin Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Frinsulin Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Reventures Venture Capital Minority
Rising S Ventures Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator
Medytox Venture Investment Corporate Venture Capital Minority
To view Frinsulin Biotech’s complete investors history, request access »

Frinsulin Biotech FAQs

  • When was Frinsulin Biotech founded?

    Frinsulin Biotech was founded in 2017.

  • Where is Frinsulin Biotech headquartered?

    Frinsulin Biotech is headquartered in Daejeon, South Korea.

  • What is the size of Frinsulin Biotech?

    Frinsulin Biotech has 5 total employees.

  • What industry is Frinsulin Biotech in?

    Frinsulin Biotech’s primary industry is Drug Discovery.

  • Is Frinsulin Biotech a private or public company?

    Frinsulin Biotech is a Private company.

  • What is Frinsulin Biotech’s current revenue?

    The current revenue for Frinsulin Biotech is .

  • Who are Frinsulin Biotech’s investors?

    Reventures, Rising S Ventures, Tech Incubator Program for Startup, and Medytox Venture Investment have invested in Frinsulin Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process